Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Chronic Lymphocytic Leukemia (CLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05322733
What this trial is testing

Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
The First Affiliated Hospital with Nanjing Medical University 25
Not applicableActive Not RecruitingNCT06205498
What this trial is testing

Acalabrutinib Real World Italian obSErvational Study -ARISE

Who this might be right for
Chronic Lymphocytic Leukemia
AstraZeneca 151
Testing effectiveness (Phase 2)Study completedNCT00241358
What this trial is testing

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, Acute+5 more
Washington University School of Medicine 92
Testing effectiveness (Phase 2)Study completedNCT01258998
What this trial is testing

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT01868893
What this trial is testing

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Genentech, Inc. 20
Early research (Phase 1)Study completedNCT00054236
What this trial is testing

Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Case Comprehensive Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT00410163
What this trial is testing

Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients

Who this might be right for
Leukaemia, Lymphocytic, Chronic
GlaxoSmithKline 61
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Not applicableWithdrawnNCT02020109
What this trial is testing

Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia

Who this might be right for
Leukemia, Chronic Lymphatic
Maastricht Radiation Oncology
Testing effectiveness (Phase 2)Study completedNCT00759798
What this trial is testing

Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaLeukemia
M.D. Anderson Cancer Center 289
Early research (Phase 1)Looking for participantsNCT06980116
What this trial is testing

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Relapsed or Refractory B-cell MalignanciesChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Follicular Lymphoma (FL)+4 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 85
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Testing effectiveness (Phase 2)Study completedNCT01063907
What this trial is testing

KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Kyowa Kirin Co., Ltd. 95
Testing effectiveness (Phase 2)WithdrawnNCT02285244
What this trial is testing

Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation

Who this might be right for
Prolymphocytic LeukemiaRecurrent Mantle Cell LymphomaRecurrent Small Lymphocytic Lymphoma+2 more
James Blachly
Testing effectiveness (Phase 2)Study completedNCT00004857
What this trial is testing

Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 86
Testing effectiveness (Phase 2)Looking for participantsNCT07108998
What this trial is testing

Study of Epcoritamab as a Consolidation Therapy in CLL/SLL

Who this might be right for
CLL/SLLCLLSLL+4 more
Zulfa Omer 22
Not applicableUnknownNCT06489184
What this trial is testing

The Real World Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China

Who this might be right for
CLL
Peking University People's Hospital 490
Early research (Phase 1)Study completedNCT00053963
What this trial is testing

FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Not applicableLooking for participantsNCT06784167
What this trial is testing

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

Who this might be right for
Chronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaFollicular Lymphoma+4 more
OHSU Knight Cancer Institute 45
Not applicableStudy completedNCT02434484
What this trial is testing

Symbenda Post-Marketing Surveillance (PMS)

Who this might be right for
Lymphoma, Non-HodgkinLymphocytic LeukemiaMultiple Myeloma
Eisai Korea Inc. 84
Next Page